% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • thirdmeinvestor thirdmeinvestor Mar 8, 2011 6:09 PM Flag

    EASL for Pharmasset

    The claimed [no resistance] is clearly stated on their slide for their NUCLEAR study presented this morning at the Cowen conf.. As AF pointed out, it is ludicrous to even mention the word for a trial that ended at Day 14. It is more absurd for analysts to take the Phase 1 data so seriously.

    We only have to remember that most nucleoside analogs failed so far. Roche's R1626, Idenix drugs, etc. A research paper describing the trial data for R1626 stated identical claims as the VRUS management is doing right now. Ask what happened to R1626.

87.21+2.21(+2.60%)Sep 30 4:00 PMEDT